SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $702,216 | +32.7% | 3,310 | +20.4% | 0.04% | +37.9% |
Q2 2023 | $529,265 | -4.9% | 2,750 | 0.0% | 0.03% | -12.1% |
Q1 2023 | $556,792 | +57.6% | 2,750 | 0.0% | 0.03% | +50.0% |
Q4 2022 | $353,402 | -6.0% | 2,750 | 0.0% | 0.02% | -15.4% |
Q3 2022 | $376,000 | -22.8% | 2,750 | 0.0% | 0.03% | -18.8% |
Q2 2022 | $487,000 | +23.0% | 2,750 | 0.0% | 0.03% | +45.5% |
Q1 2022 | $396,000 | -6.8% | 2,750 | 0.0% | 0.02% | +4.8% |
Q4 2021 | $425,000 | -9.0% | 2,750 | 0.0% | 0.02% | -19.2% |
Q3 2021 | $467,000 | +64.4% | 2,750 | +52.8% | 0.03% | +62.5% |
Q2 2021 | $284,000 | +13.6% | 1,800 | 0.0% | 0.02% | +6.7% |
Q1 2021 | $250,000 | -20.6% | 1,800 | 0.0% | 0.02% | -25.0% |
Q4 2020 | $315,000 | +21.6% | 1,800 | +35.8% | 0.02% | +5.3% |
Q3 2020 | $259,000 | +13.1% | 1,325 | -1.5% | 0.02% | +5.6% |
Q2 2020 | $229,000 | – | 1,345 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |